Dogwood Therapeutics, Inc.
DWTXNasdaqCIK 1818844HealthcareFiscal year ends Dec 31
Reports and events: 120 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2716:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-119153 |
| 2026-10-2116:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-117841 |
| 2026-10-1908:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-116748 |
| 2026-08-1411:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-096719 |
| 2026-08-1308:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095512 |
| 2026-06-1716:55 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075204 |
| 2026-05-1509:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-061938 |
| 2026-05-1408:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060747 |
| 2026-04-2714:30 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001104659-26-049277 |
| 2026-03-2609:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-034928 |
| 2026-03-1816:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-031061 |
| 2026-03-1809:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-029992 |
| 2026-03-1216:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-027090 |
| 2026-02-1316:05 ET | DEF 14A | Proxy statementPeriod 2026-03-11 | 0001104659-26-015180 |
| 2026-01-2008:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-004838 |
| 2026-01-1312:38 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003211 |
| 2025-11-2814:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-116865 |
| 2025-11-2517:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-116057 |
| 2025-11-2113:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-114919 |
| 2025-11-0708:45 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-108169 |
| 2025-11-0609:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107471 |
| 2025-10-2016:30 ET | DEF 14A | Proxy statementPeriod 2025-11-21 | 0001104659-25-100850 |
| 2025-10-0916:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-098360 |
| 2025-09-2907:34 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-094109 |
| 2025-08-1310:18 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011319 |
| 2025-08-1309:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011311 |
| 2025-07-0216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-009060 |
| 2025-06-2410:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008817 |
| 2025-05-0911:28 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007109 |
| 2025-05-0809:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006866 |
| 2025-04-3008:00 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001558370-25-005927 |
| 2025-04-0309:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004362 |
| 2025-03-3116:44 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004167 |
| 2025-03-3115:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-004150 |
| 2025-03-1721:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-024579 |
| 2025-03-1411:47 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-002978 |
| 2025-03-1209:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-002750 |
| 2024-12-1809:30 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001558370-24-016346 |
| 2024-11-2109:15 ET | 8-K | 3.01 Delisting notice | 0001558370-24-015884 |
| 2024-11-0808:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014957 |
| 2024-11-0707:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014749 |
| 2024-10-3009:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013889 |
| 2024-10-1516:19 ET | SC 13D | Ownership report, active investor | 0001104659-24-108596 |
| 2024-10-0708:02 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013167 |
| 2024-08-0910:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011686 |
| 2024-08-0809:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011486 |
| 2024-06-2009:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-009327 |
| 2024-06-1209:15 ET | 8-K | 3.01 Delisting notice | 0001558370-24-009066 |
| 2024-05-2009:28 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-008450 |
| 2024-05-1010:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007713 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.